Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics.

Antoine TE, Park PJ, Shukla D.

Rev Med Virol. 2013 May;23(3):194-208. doi: 10.1002/rmv.1740. Epub 2013 Feb 26. Review.

2.

Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.

Lin LT, Chen TY, Chung CY, Noyce RS, Grindley TB, McCormick C, Lin TC, Wang GH, Lin CC, Richardson CD.

J Virol. 2011 May;85(9):4386-98. doi: 10.1128/JVI.01492-10. Epub 2011 Feb 9.

3.

Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.

Zheng K, Chen M, Xiang Y, Ma K, Jin F, Wang X, Wang X, Wang S, Wang Y.

Biochem Biophys Res Commun. 2014 Apr 18;446(4):990-6. doi: 10.1016/j.bbrc.2014.03.050. Epub 2014 Mar 19.

PMID:
24657267
4.

Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.

Antoine TE, Shukla D.

Antivir Ther. 2014;19(1):15-29. doi: 10.3851/IMP2661. Epub 2013 Jun 28.

PMID:
23813409
5.

Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1.

Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y.

Nature. 2010 Oct 14;467(7317):859-62. doi: 10.1038/nature09420.

PMID:
20944748
6.

Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.

Hubbard S, Choudhary S, Maus E, Shukla D, Swenson S, Markland FS Jr, Tiwari V.

Antivir Ther. 2012;17(7):1319-26. doi: 10.3851/IMP2291. Epub 2012 Aug 8.

PMID:
22875654
7.

Exploiting herpes simplex virus entry for novel therapeutics.

Hadigal S, Shukla D.

Viruses. 2013 Jun 10;5(6):1447-65. doi: 10.3390/v5061447. Review.

8.

Anti-HSV activity of digitoxin and its possible mechanisms.

Su CT, Hsu JT, Hsieh HP, Lin PH, Chen TC, Kao CL, Lee CN, Chang SY.

Antiviral Res. 2008 Jul;79(1):62-70. doi: 10.1016/j.antiviral.2008.01.156. Epub 2008 Feb 21.

PMID:
18353452
9.

A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.

Tiwari V, Shukla SY, Shukla D.

Antiviral Res. 2009 Oct;84(1):67-75. doi: 10.1016/j.antiviral.2009.07.014. Epub 2009 Aug 7.

10.

Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Antoine TE, Mishra YK, Trigilio J, Tiwari V, Adelung R, Shukla D.

Antiviral Res. 2012 Dec;96(3):363-75. doi: 10.1016/j.antiviral.2012.09.020. Epub 2012 Oct 6.

11.

Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.

Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ.

Antiviral Res. 2006 Dec;72(3):242-51. Epub 2006 Jul 14.

PMID:
16876885
12.

The amino terminus of herpes simplex virus 1 glycoprotein K is required for virion entry via the paired immunoglobulin-like type-2 receptor alpha.

Chowdhury S, Chouljenko VN, Naderi M, Kousoulas KG.

J Virol. 2013 Mar;87(6):3305-13. doi: 10.1128/JVI.02982-12. Epub 2013 Jan 9.

13.

Dendrimers functionalized with membrane-interacting peptides for viral inhibition.

Tarallo R, Carberry TP, Falanga A, Vitiello M, Galdiero S, Galdiero M, Weck M.

Int J Nanomedicine. 2013;8:521-34. doi: 10.2147/IJN.S37739. Epub 2013 Feb 5.

14.

A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.

Ali MM, Karasneh GA, Jarding MJ, Tiwari V, Shukla D.

J Virol. 2012 Jun;86(12):6434-43. doi: 10.1128/JVI.00433-12. Epub 2012 Apr 4.

15.

Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96.

Schwartz JA, Lium EK, Silverstein SJ.

J Virol. 2001 May;75(9):4117-28.

16.

Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.

Watkins AM, Dunford PJ, Moffatt AM, Wong-Kai-In P, Holland MJ, Pole DS, Thomas GM, Martin J, Roberts NA, Mulqueen MJ.

Antivir Chem Chemother. 1998 Jan;9(1):9-18.

PMID:
9875372
17.

An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread.

Karasneh GA, Ali M, Shukla D.

PLoS One. 2011;6(9):e25252. doi: 10.1371/journal.pone.0025252. Epub 2011 Sep 21.

18.

Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.

Gong Y, Matthews B, Cheung D, Tam T, Gadawski I, Leung D, Holan G, Raff J, Sacks S.

Antiviral Res. 2002 Aug;55(2):319-29.

PMID:
12103432
19.

Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry.

Akhtar J, Shukla D.

FEBS J. 2009 Dec;276(24):7228-36. doi: 10.1111/j.1742-4658.2009.07402.x. Epub . Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk